Beam Therapeutics

Biotechnology company pioneering base editing, a next-generation precision gene editing technology that enables programmable, precise single base changes in DNA without creating double-strand breaks.

Location
Cambridge, Massachusetts, USA
Founded
2017
Investors
1
Categories
biotech, gene-editing, base-editing, therapeutics, genetic-diseases

Investors

NameLocationTypeStagesPortfolio
Redmile Group-healthcare-focused-1